What is the ROCE (Return on Capital Employed) of aTyr Pharma this year?
The ROCE of aTyr Pharma is -0.61 undefined this year.
aTyr Pharma ROCE 2024
aTyr Pharma ROCE
-0.61
aTyr Pharma Dividend yield
Ticker
LIFE
ISIN
US0021202025
WKN
A2PM86
In 2024, aTyr Pharma's return on capital employed (ROCE) was -0.61, a -6.65% increase from the -0.65 ROCE in the previous year.
aTyr Pharma Aktienanalyse
What does aTyr Pharma do?
aTyr Pharma Inc is a biotechnology company based in San Diego, California. Founded in 2005, the company has gained a lot of attention in recent years for its focus on developing drugs based on proteomics, the analysis of proteins. The idea for aTyr came from the realization that there are a variety of proteins that can be used as a basis for developing new drugs. The company has developed a unique proteomics platform that allows for the identification and utilization of previously undiscovered proteins to understand biological processes and develop new drugs for diseases. aTyr specializes in the discovery and development of proteins associated with rare but difficult-to-treat diseases. This includes rare muscle diseases and lung diseases. The company collaborates closely with clinicians and scientists to advance its research and development. aTyr's business model is based on the development of new drugs based on proteomics, with a focus on rare diseases that are often neglected. The goal is to improve the quality of life for patients by developing new and innovative drugs. aTyr has various divisions, including therapeutic proteins and diagnostics. The company has a number of drugs in development targeting different diseases. This includes Resolaris, a protein focused on rare muscle diseases, and ATYR1923, developed for the treatment of lung diseases. Resolaris is a novel protein targeting rare muscle diseases such as FSHD and LGMD. It is currently being tested in clinical trials and has the potential to significantly improve the quality of life for patients with these severe conditions. The company is also developing ATYR1923, a protein for the treatment of lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Overall, aTyr Pharma is an innovative company focused on the development of novel drugs based on proteomics. With its unique proteomics platform, the company has the potential to identify and utilize previously undiscovered proteins to understand biological processes and develop new drugs for diseases. With its various divisions, including therapeutic proteins and diagnostics, the company has the potential to improve the treatment of rare and difficult-to-treat diseases and enhance the lives of patients worldwide. aTyr Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling aTyr Pharma's Return on Capital Employed (ROCE)
aTyr Pharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing aTyr Pharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
aTyr Pharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in aTyr Pharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about aTyr Pharma Stock
How has the ROCE (Return on Capital Employed) of aTyr Pharma developed compared to the previous year?
The ROCE of aTyr Pharma has increased by -6.65% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of aTyr Pharma?
A high Return on Capital Employed (ROCE) indicates that aTyr Pharma has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of aTyr Pharma?
A low ROCE (Return on Capital Employed) can indicate that aTyr Pharma has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from aTyr Pharma impact the company?
An increase in the ROCE of aTyr Pharma can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of aTyr Pharma affect the company?
A decrease in ROCE of aTyr Pharma can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of aTyr Pharma?
Some factors that can affect aTyr Pharma's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of aTyr Pharma so important for investors?
The ROCE of aTyr Pharma is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can aTyr Pharma take to improve the ROCE?
To improve the ROCE, aTyr Pharma can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does aTyr Pharma pay?
Over the past 12 months, aTyr Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, aTyr Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of aTyr Pharma?
The current dividend yield of aTyr Pharma is .
When does aTyr Pharma pay dividends?
aTyr Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of aTyr Pharma?
aTyr Pharma paid dividends every year for the past 0 years.
What is the dividend of aTyr Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is aTyr Pharma located?
aTyr Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von aTyr Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of aTyr Pharma from 4/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.
When did aTyr Pharma pay the last dividend?
The last dividend was paid out on 4/26/2024.
What was the dividend of aTyr Pharma in the year 2023?
In the year 2023, aTyr Pharma distributed 0 USD as dividends.
In which currency does aTyr Pharma pay out the dividend?
The dividends of aTyr Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The aTyr Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von aTyr Pharma
Our stock analysis for aTyr Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of aTyr Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
